Key Financial Figures (₹ in Lakhs)

Income Statement

Revenue from Operations: ₹89,146

  • Sale of Products: ₹88,992
  • Other Operating Revenues: ₹154

Total Income: ₹90,089 (Revenue from Operations + Other Income of ₹943)

Expenses: ₹73,126

  • Cost of raw and packing materials consumed: ₹20,024
  • Purchases of stock-in-trade (Traded goods): ₹21,323
  • Changes in inventories: (₹3,322) [Credit]
  • Employee benefits expense: ₹5,436
  • Finance costs: ₹27
  • Depreciation and amortization expense: ₹959
  • Advertising & sales promotion expenses: ₹8,332
  • Other expenses: ₹20,347

Profit Before Tax (PBT): ₹16,963

Income Tax Expense: ₹4,336

  • Current tax: ₹4,389
  • Deferred tax: (₹53) [Credit]
  • Prior year tax adjustments: ₹0

Profit for the Period (Net Profit): ₹12,627

Other Comprehensive Income: ₹107 (Net of tax)

Total Comprehensive Income for the Period: ₹12,734

Comparative Performance

| Particulars | Q1 FY2027 (30 Jun 2026) | Q4 FY2026 (31 Mar 2026) | Q1 FY2026 (30 Jun 2025) | Full Year FY2026 (31 Mar 2026) |

| Revenue | ₹89,146 | ₹94,132 | ₹93,703 | ₹4,29,042 |

| Total Income | ₹90,089 | ₹95,379 | ₹94,472 | ₹4,33,289 |

| Net Profit | ₹12,627 | ₹15,313 | ₹19,206 | ₹85,650 |

| EPS - Basic (₹) | 38.90 | 47.17 | 59.17 | 263.86 |

| EPS - Diluted (₹) | 38.90 | 47.17 | 59.17 | 263.86 |

YoY Change (Q1 FY2027 vs Q1 FY2026):

  • Revenue decreased by 4.8% (from ₹93,703 lakhs to ₹89,146 lakhs).
  • Net Profit decreased by 34.6% (from ₹19,206 lakhs to ₹12,627 lakhs).
  • EPS decreased by 34.3% (from ₹59.17 to ₹38.90).

QoQ Change (Q1 FY2027 vs Q4 FY2026):

  • Revenue decreased by 5.3% (from ₹94,132 lakhs to ₹89,146 lakhs).
  • Net Profit decreased by 17.5% (from ₹15,313 lakhs to ₹12,627 lakhs).
  • EPS decreased by 17.5% (from ₹47.17 to ₹38.90).

Capital Structure

Paid-up Equity Share Capital: ₹3,246 lakhs (Face Value ₹10 per equity share). This remained unchanged from the previous quarter and the previous year.

Segment Information

The company has a single reportable segment: "manufacturing, trading and marketing of Health and Hygiene Products." This segment is an aggregation of two operating segments:

1. Health Care Products: Comprising Ointment and Creams, Cough Drops and Tablets.

2. Hygiene Products: Comprising Feminine Hygiene products and other skin care hygiene.

Other Information

Subsidiaries/JVs: The company does not have any subsidiary, associate, or joint venture as of June 30, 2026.

Auditor's Review: The financial results were subjected to a limited review by the statutory auditors, Kalyaniwalla & Mistry LLP. Their review report, issued on July 29, 2026, states that nothing has come to their attention that causes them to believe the statement contains any material misstatement.

Note on Preceding Quarter Figures: The figures for the three months ended March 31, 2026 (Q4 FY2026), are balancing figures between the audited full-year results and the published year-to-date figures up to the third quarter of FY2026. These figures were reviewed but not audited.

Signatories: The results were signed by Flavia Machado, Authorized Signatory, and Kumar Venkatasubramanian, Managing Director.

#P&GHygiene #Earnings #Q1FY2027 #SEBIDisclosure #RegulatoryCompliance #FinancialUpdate #Neutral